Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

James R Neal

Director at Processa Pharmaceuticals, Inc. (PCSA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$805
Total bought / sold$2K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Apr 2SEC PCSAProcessa Pharmaceuticals, Inc. Buy 789818 held (+2721%) $2.54 $2K -40.2%
  • Buy

    Director James R Neal bought $2K of PCSA at $2.54 — first open-market purchase in our records; raises the stake by 2721%.